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Abstract
Acetylcholinesterase (AChE) activity is increased within and around amyloid plaques, which are present in Alzheimer’s disease
(AD) patient’s brain. In this study, using cultured retinal cells as a neuronal model, we analyzed the effect of the synthetic peptide
Ab25 35 on the activity of AChE, the degradation enzyme of acetylcholine, as well as the involvement of oxidative stress in this
process. The activity of AChE was increased when retinal cells were incubated with Ab2535 (25 mM, 24 h) and antioxidants such as
a-tocopherol acetate and nitric oxide synthase (NOS) inhibitors were capable of preventing this effect. Despite Ab25 35 did not
affect cell membrane integrity, the redox capacity of cells decreased. The incubation with this amyloidogenic peptide led to an
increment of reactive oxygen species formation (20%), of lipid peroxidation (65%), and basal intracellular calcium levels (40%). The
data obtained show that the enhancement of AChE activity induced by Ab2535 is mediated by oxidative stress, and that vitamin E
and NOS inhibitors, by preventing the compromise of the enzyme activity, can have an important role in the maintenance of
acetylcholine synaptic levels, thus preventing or improving cognitive and memory functions of AD patients.
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1. Introduction
The major constituent of senile plaques, occurring in
Alzheimer’s disease (AD), is amyloid b-peptide (Ab), a
40/42 amino acid peptide, which is a cleaved form of
the amyloid precursor protein (APP) (Kang et al., 1987;
Tanzi et al., 1988). Ab seems to play a crucial role in the
pathogenesis of AD, however the mechanism and the
cellular pathways involved in the neuronal degeneration
induced by this peptide are not fully understood. It was
demonstrated that above a threshold concentration Ab
peptides act as potent neurotoxins both in vitro and in
vivo (Pereira et al., 1999; Harkany et al., 1999; Kasa et
al., 2000; Zhu et al., 2000). Accumulating evidence
suggests that oxidative stress is involved in the mechan-
ism of Ab-induced neurotoxicity (Behl et al., 1992;
Butterfield et al., 1994; Mattson et al., 1995; Bus et al.,
1999; Huang et al., 1999; Pereira et al., 1999).
Besides Ab deposition, selective neuronal loss is
another hallmark of AD brains, especially with dysfunc-
tion and degeneration of basal forebrain cholinergic
neurons, which project to hippocampus and neocortex
(Geula and Mesulam, 1994). However, the cause of the
basal forebrain cholinergic neurons vulnerability and its
relationship to Ab peptides remains unclear. One of the
characteristic changes that occurs in AD is the loss of
acetylcholinesterase (AChE) activity, the enzyme re-
sponsible for acetylcholine hydrolysis, from both choli-
nergic and non-cholinergic neurons of the brain (Atack
et al., 1983). However, AChE activity has been shown to
be increased within and around amyloid plaques (Ulrich
et al., 1990; Mora´n et al., 1993), to promote the
assembly of amyloid beta-peptides into fibrils (Inestrosa
et al., 1996) and to increase the cytotoxicity of these
peptides (Alvarez et al., 1998). These reports suggest
that AChE could play a pathogenic role in AD by
influencing the process leading to amyloid toxicity.
In this study we assessed AChE activity and the
kinetic parameters of the enzyme activity when cells are
incubated with Ab2535. Considering that Ab2535 is
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known to induce cytotoxicity through mechanisms
involving oxidative stress, we studied the effect of
some antioxidants in preventing the increase of AChE
activity induced by Ab2535, using chick retinal cells as a
neuronal model.
2. Materials and methods
2.1. Material
Basal Medium Eagle (BME) was purchased from
Sigma, USA; trypsin from Gibco and fetal calf serum
from Biochrom, KG. The synthetic peptides Ab2535
and Ab3525 were obtained from Bachem, Germany. 1-
(4-(Trimethylammonium)-phenyl)-6-phenylhexa-1,3,5-
triene (TMA-DPH) and 2?,7?-dichlorofluorescin diace-
tate (DCFH2-DA) were obtained from Molecular
Probes, Eugene, OR. D-a-Tocopherol acetate (vitamin
E) was purchased from Fluka, Buchs, Switzerland. L-
NAME and 7-nitroindazole were obtained from Sigma,
USA. All other chemicals used were purchased from
Sigma, USA or Merck, Germany, and were of analytical
grade.
2.2. Culture of chick retinal cells
Retinal cells were prepared from 8-day-old chick
(White Leghorn) embryos and cultured in BME, buf-
fered with 20 mM Hepes and 10 mM NaHCO3, and
supplemented with 5% fetal calf serum, penicillin (100
U/ml) and streptomycin (100 mg/ml) as previously
described (Agostinho et al., 1994). The cells were plated
at density of a 0.4/106 cells/cm2 on poly-L-lysine (0.1
mg/ml) coated glass coverslips, for fluorescence mea-
surements and on 12-multiwell plates, also coated with
poly-L-lysine, for the other experiments. The cells were
kept in culture for 5/6 days at 37 8C in a humidified
atmosphere of 5% CO2 and 95% air, before the
experiments. Similar cultures were previously described
to be enriched in amacrine-like neurons, but also
containing neurons resembling bipolar cells and a few
glial cells (Agostinho et al., 1996; Carvalho et al., 1998).
2.3. Cell treatments and viability analysis
The peptides Ab2535 or Ab3525, previously solubi-
lized in sterile miliQ water, were added to the culture
medium 24 h before the experiments in a final concen-
tration of 25 mM. Vitamin E (D-a-tocopherol acetate),
solubilized in dimethyl sulfoxide (DMSO), was added to
the cells 20 h before the exposure to the peptide in a final
concentration of 20 mM. The final concentration of
DMSO was 0.2%, and did not affect cell viability (data
not show). L-NAME (250 mM) and 7-nitroindazole (50
mM), solubilized in water, were incubated 30 min before
exposure of cells to the peptide.
The viability of retinal cells was determined by
monitoring the leakage of lactate dehydrogenase
(LDH) and the capacity of the cells to reduce the 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) salt to formazan. LDH activity was
measured spectrophotometrically, according to the
method described by Bergmeyer and Brent (1974),
following the rate of conversion of NADH to NAD
at 340 nm. To calculate the intracellular LDH activity
the cells were lysed with 10 mM Hepes (pH 7.4). LDH
released into the extracellular medium was expressed as
a percentage of the total LDH activity in the cells. The
ability of cells to reduce MTT was measured spectro-
photometrically at 570 nm, according to Mosmann
(1983). In brief, MTT, dissolved in sodium medium
(pH 7.4) at 5 mg/ml, was incubated with the cells for 3 h
at 37 8C. After this period an equal volume of acid
isopropanol (0.04 M HCl in isopropanol) was added to
each well and mixed until all the formazan crystals were
dissolved. MTT reduction was expressed as a percentage
of control cells absorbance.
2.4. AChE activity
Cells were lysed in 15 mM Tris (pH 7.4), on ice, and
AChE activity was measured using a spectrophoto-
metric method (Ellman et al., 1961; Harkany et al.,
1999). Acetylthiocholine iodide (ACThCh) was used as
a substrate, in a concentration of 0.5 mM.
Ethopropasine/HCl (104 M) was used to inhibit
non-specific esterases. The activity of AChE was ex-
pressed as nanomole of ACThCh hydrolyzed/min/mg
protein, as measured spectrophotometrically at 414 nm.
The kinetics of AChE was determined by using increas-
ing concentrations of acetylthiocholine, in the range of
0.03/1.0 mM. The Km and Vmax values of the enzyme
were calculated by regression analysis of the linear
portions of the Lineweaver/Burk plots (1/V vs 1/S )
(Alvarez et al., 1998).
2.5. Measurement of intracellular reactive oxygen species
formation
Formation of intracellular peroxides was detected by
fluorescence spectroscopy using a non-fluorescent com-
pound, DCFH2-DA, which is desterified within cells by
endogenous esterases to the acid 2?,7?-dichlorofluorescin
(DCFH2), as previously described (Pereira et al., 1999).
This ionized free acid is trapped within the cells and is
capable of being oxidized to fluorescent 2?,7?-dichloro-
fluorescein (DCF) by hydroperoxides, although other
mechanism of oxidation cannot be ruled out (Cathcart
et al., 1983). Retinal cells, cultured in glass coverslips,
were loaded with 5 mM DCFH2-DA for 30 min, at
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37 8C, in a saline medium (Na-medium) containing
(in mM): 132.0 NaCl, 4.0 KCl, 1.0 CaCl2, 1.4 MgCl2, 1.2
NaH2PO4, 6.0 glucose, 10.0 Hepes (pH 7.4). Then, the
cells were washed and were incubated in Na-medium,
for 15 min at 37 8C, to allow desterification of DCFH2-
DA. After this period, the glass coverslips were mounted
in a special holder (Perkin-Elmer L225008) and fluores-
cence was measured using a computer-assisted spectro-
fluorophotometer, at 502 nm excitation and 550 nm
emission, for 30 min.
2.6. Measurement of the extent of lipid peroxidation
The extent of lipid peroxidation was determined by
the thiobarbituric acid method (Buege and Aust, 1967).
After exposure of cells to Ab2535 peptide, the culture
medium was removed and replaced by an ice-cold
solution of 15 mM Tris (pH 7.4), with the multi-wells
on ice. The cells were scrapped off and diluted three
times with 15% trichloroacetic acid (TCA), 0.375%
thiobarbituric acid, 0.25 M HCl, and 0.015% 2,6-di-
tert -butyl-4-methylphenol (BHT), and incubated for 15
min at 100 8C. Then, the samples were centrifuged at
95.5/gav for 10 min, the supernatants were collected
and the absorbance was measured at 530 nm. The
amount of thiobarbituric acid-reactive substances
(TBARS) formed was calculated using a molar extinc-
tion coefficient of 1.56/105/mol/cm and expressed as
nanomoles of TBARS produced per milligram of
protein. Protein content was determined by the Sedmak
method (Sedmak and Grossero, 1977), using bovine
serum albumin as the standard.
2.7. [Ca2]i measurements
Retina cells cultured on glass coverslips were incu-
bated with 3 mM Indo-AM, in BME buffered with 20
mM Hepes, for 45 min at 37 8C. The cells were further
incubated in Krebs buffer containing (in mM): 132
NaCl, 4 KCl, 1 CaCl2, 1.4 MgCl2, 6 glucose and 10
Hepes, (pH 7.4) for 15 min, to allow the complete
hydrolysis of the acetoxymethylester precursor of Indo-
1. Then, the cells were rinsed with Krebs buffer and
placed in a special holder (Perkin-Elmer L225008),
inside a cuvette with an alignment of 608 to the
excitation beam in order to minimize the effect of light
reflection. The fluorescence was measured with excita-
tion of 335 nm and emission at 410 nm, using 5 nm slits.
The free intracellular Ca2 concentration [Ca2]i was
calculated as previously described (Agostinho et al.,
1997), Fmax being calculated upon addition of 3 mM
ionomycin, and the autofluorescence determined with 3
mM MnCl2.
2.8. Membrane anisotropy measurements
For these experiments, retinal cells were cultured in
glass coverslips and the membrane order was measured
by fluorescence analysis, by using the probe TMA-DPH,
as previously described (Rego et al., 1998). After
incubation with the peptides or/and vitamin E, the
coverslips were washed with a sodium saline solution
(pH 7.4) and placed in a special holder (Perkin-Elmer
L225008) inside a cuvette with an alignment of 608 to
the excitation beam, in order to minimize the effect of
light reflection. Then, TMA-DPH at a final concentra-
tion of 1.5 mM, was added and after 20 min fluorescence
anisotropy was determined using a computer-assisted
spectrofluorophotometer (Perkin-Elmer LS 50 B) with a
controlled polarizer system, with excitation wavelength
at 360 nm and emission at 430 nm. The probe showed to
be rapidly incorporated in retinal cells, the labeling by
TMA-DPH being maximal after about 15/20 min, as
determined by a time drive fluorescence measurement
(not shown). The fluorescence anisotropy data were
calculated according to Shinitzky and Barenholz (1978).
An increase in fluorescence anisotropy (r) values
indicates a decrease in the probe mobility, reflecting an
increase in membrane structural order or, in other
terms, a decrease in membrane fluidity (Van Blitterswijk
et al., 1981).
2.9. Protein oxidation determination
Protein carbonyl content was determined as described
by Levine et al. (1990) with slight modifications
(Cardoso et al., 1999). Cell suspensions were incubated
with 10 mM DNPH in 2 N HCl (or with 2 N HCl alone
for the blanks), for 1 h at room temperature. The
protein hidrazone derivatives were precipitated with
20% TCA, and the precipitates were washed three times
with ethanol:ethylacetate (1:1). The final pellet was
ressuspended and incubated in 6 M guanidine HCl, for
15 min at 37 8C. The carbonyl content was determined
spectrophotometrically at 360 nm (o/22 000/M/cm)
and expressed as nmol/mg protein.
2.10. Statistical analysis
All data were expressed as mean 9/SEM. Statistical
significance analysis was determined by using the
unpaired two-tailed Student’s t-test, after analysis of
variance. A P value less than 0.05 was considered
significant.
3. Results
Retinal cells in culture were used as a neuronal model
(Santos et al., 1998), in order to study the effect of the
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amyloidogenic peptide Ab2535 on AChE activity and to
evaluate whether oxidative stress is involved in this
process. Retinal cells were incubated during 24 h with
the synthetic peptide Ab2535, the neurotoxic sequence
of Ab protein (Pike et al., 1993; Pereira et al., 1999), in a
final concentration of 25 mM. The reverse non-toxic
sequence of Ab2535 peptide (Ab3525) was used as a
control. In our experimental conditions, the exposition
of cells to Ab2535 for 24 h did not affect cell membrane
integrity, as assessed by the leakage of the cytoplasmatic
enzyme LDH. Indeed, the amount of LDH released by
control cells and by cells treated with the reverse
sequence peptide, Ab3525, (14.29/1.0% of total and
13.69/1.3% of total, respectively) was not significantly
(P/0.05) different from that released by cells treated
with Ab2535 peptide (15.49/1.17% of total) (Table 1).
However, the cellular capacity to reduce the tetrazolium
salt MTT was decreased upon incubation with Ab2535
(65.89/1.6%), when compared to control cells (100.19/
2.0%) or with cells treated with the reverse sequence
peptide Ab3525 (97.89/4.4%), as showed in Table 1. A
dose-response curve of the effect of Ab2535 peptide (5/
100 mM) on MTT reduction (Fig. 1) was performed, and
it was observed that 25 mM of this peptide induces a
significant (PB/0.01) decrease of cellular metabolic
activity without affecting cell membrane integrity. The
effect of 5 mM of the full-length peptide Ab140,
incubated for 24 h, on cellular capacity to reduce
MTT was similar (66.69/3.4%) to the effect observed
for the synthetic peptide Ab2535 (25mM; 24 h) (data not
shown). Once, it has been reported that Ab2535
accelerates the MTT formazan exocytosis (Liu and
Schubert, 1997; Abe and Saito, 1999), cells treated or
not (control cells) with Ab2535, for 24 h, were incubated
with MTT solution for different times (0/180 min). It
was observed that in Ab2535-treated cells the amount of
MTT formazan formed was lower than that occurring in
control cells for all the times studied (Fig. 1B). These
results suggest an alteration in metabolic activity, rather
than an effect on MTT formazan exocytosis induced by
Ab2535 peptide. Furthermore, we have recently shown
that Ab2535 induces a decrease in glucose uptake and in
pyruvate levels, thus reforcing the impairment of meta-
bolic activity caused by this peptide. (Melo et al., in
press).
3.1. Ab2535 increases AChE activity
The activity of AChE, the enzyme responsible for
acetylcholine degradation, was significantly increased
(PB/0.001) in cells incubated with the Ab2535 peptide
(25 mM for 24 h) when comparing with cells treated with
the reverse sequence peptide Ab3525 (25 mM, 24 h) or
with untreated cells (Fig. 2). In cells treated with
Ab2535 for 18 h the activity of AChE (1029/7.4% of
control cells) was not significantly (P/0.05) different
Table 1
Effect of Ab peptides on LDH leakage and on MTT reduction, in
retinal cells
Control Ab35  25 Ab25  35
% LDH release 14.291.0 (13) 13.691.3 (4) 15.491.17 (9)
% MTT reduction 100.192.0 (14) 97.894.4 (6) 65.891.6 (12)
Cultured retinal cells were exposed to 25 mM of Ab35  25 or Ab25  35
peptide, for 24 h. LDH release and MTT reduction ability were
determined spectrophotometrically, as described in Section 2. Values
represent means9SEM of the number of experiments indicated, run in
duplicate.
 PB0.01 values significantly different from cells not treated
(control cells).
Fig. 1. Effect of Ab25  35 peptide on cellular metabolic capacity,
assessed by MTT assay. (A) After treatment with the peptide at
various concentrations (0, 5, 10, 15, 25, 50 and 100 mM) for 24 h, the
reduction of the tetrazolium salt MTT to formazan was measured
spectrophotometrically at 570 nm, and expressed as a percentage
relatively to control cells. Insert. Effect of Ab25  35 peptide (25 mM) on
cellular metabolic capacity after 24 h or 48 h of treatment; (B) Time-
course of the amount of MTT formazan formed in control (k) and
Ab25  35 peptide-treated cells (m). The values represent means9/SEM
of 3/14 experiences run in duplicate. PB/0.05 values significantly
different from cells not treated with Ab25  35; PB/0.01 values
significantly different from cells not treated with Ab25  35.
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from that achieved in control cells, whereas for 24 h of
treatment a significant increase of about 30% was
observed. The effect of Ab2535 peptide was shown to
be specific, since in the presence of the reverse sequence
of the peptide AChE activity (101.79/5.5%) was iden-
tical to that one observed in control cells (96.49/3.4%).
When AChE activity was measured in the presence of
increasing substrate concentrations, an increment in
enzyme activity in Ab2535 treated cells was observed,
although showing the same enzymatic activity profile
(Fig. 3A). Fig. 3B represents the Lineweaver/Burk plot
(1/V vs 1/S ) obtained for AChE activity of cells treated
with Ab2535 peptide and control cells. Km values, the
substrate concentration that gives half of maximal
reaction velocity (Vmax), and Vmax values were calcu-
lated by determining the y-intersection (1/Km) and the x-
intersection (1/Vmax) of the Lineweaver/Burk plots. As
can be observed in Table 2, the values of Vmax for
Ab2535 treated cells (0.2349/0.02 mmol AchThCh/
min mgprot.) were significantly (PB/0.05) higher than
the values determined in control cells (0.1849/0.02 mmol
AchThCh/min mgprot.). In contrast, the Km value was
lower in cells incubated in the presence of Ab2535 (0.068
mM) than in untreated cells (0.096 mM), suggesting an
increase in the substrate-AChE affinity, in the presence
of the peptide.
In order to exclude the possibility of Ab inclusion in
the sample might interfere with the measurement of
AChE, the enzyme activity was determined after addi-
tion or not of 25 mM Ab2535, 15 min prior to the
measurement, to extracts of untreated cells. Since no
differences in AChE activity were observed, we can
conclude that the inclusion of Ab does not interfere with
the measurement of this enzyme activity (data not
shown).
3.2. Oxidative stress induced by Ab2535 affects AChE
activity
In an attempt to clarify the involvement of oxidative
stress in Ab neurotoxicity, we measured the accumula-
tion of reactive oxygen species (ROS) after the exposure
of the cells to 25 mM Ab2535 for 24 h (Fig. 4).
Intracellular ROS concentration, estimated by the con-
version of the fluorescent probe DCFH2-DA to DCF,
was significantly (PB/ 0.05) higher in cells incubated
with the Ab2535 peptide for 24 h (1.259/0.05 a.u.) or for
18 h (1.199/0.09 a.u.) than in untreated cells (1.059/0.01
a.u.). A pre-treatment with the antioxidant vitamin E
(20 mM), 20 h prior to the incubation with Ab2535,
prevented intracellular ROS production (1.099/0.03
a.u.). The antioxidant did not affect cell viability, as
assessed by the ability of cells to reduce MTT (100.69/
4.9% MTT reduction) or by LDH release (13.39/1.3%
LDH release), even when incubated during 44 h (data
not shown). Fig. 5 shows that the incubation of retinal
cells with Ab2535 significantly (PB/ 0.05) increased the
production of TBARS (4.369/0.44 nmol TBARS/mg
prot) as compared to control cells (2.599/0.25 nmol
TBARS/mg prot). These data suggest an increment in
lipid peroxidation, that is prevented by pre-treating the
cells with vitamin E (20 mM, 20 h) (2.649/0.19 nmol
TBARS/mg prot) in a significant manner (PB/ 0.05).
Protein carbonyl content was not affected by the
incubation of retinal cells with Ab2535 peptide (Table
3).
In order to understand if oxidative stress is involved
in the increase of AChE activity induced by Ab2535, the
effect of some antioxidants on enzyme activity was
studied (Fig. 2). In cells pre-incubated with the
lipophylic antioxidant vitamin E (20 mM, 20 h) prior
to Ab2535 treatment (25 mM, 24 h) the AChE activity
Fig. 2. AChE activity in retinal cells treated with Ab25  35 or Ab35  25 peptide (25 mM, 24 h), in cells incubated with antioxidants (20 mM vitamin E,
250 mM L-NAME or 50 mM 7-nitroindazole) in the absence or in the presence of 25 mM Ab25  35, and in control cells. AChE activity was measured
spectrophotometricaly using AcThCh (0.5 mM) as a substrate and ethopropasine (104 M) as an inhibitor of non-specific esterases. The values were
expressed as a percentage of AChE activity in control cells and are the mean9/SEM of 8/30 experiments. PB/0.001 values significantly different
from cells not treated with Ab25  35; PB/0.01 values significantly different from retinal cells incubated with Ab25  35.
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(87.79/4.9%) was similar to that observed for untreated
cells and significantly (PB/0.01) lower than the activity
obtained for Ab2535 treated cells. Pre-treatment of
retinal cells with nitric oxide synthase (NOS) inhibitors,
7-nitroindazole and L-NAME, was also able of prevent-
ing the effect of Ab2535 on AChE activity (83.89/6.5%
and 97.79/6.0%, respectively). Vitamin E and NOS
inhibitors per se did not affect AChE activity (Fig. 2).
Furthermore, vitamin E was also able to prevent the
change of membrane order induced by Ab2535. Indeed,
as can be observed in Fig. 6, the anisotropy fluorescence
values of TMA-DPH in cells pre-incubated with vitamin
E prior (20 mM, 20 h) to Ab2535 treatment (0.3079/
0.002) were significantly (PB/ 0.01) different from those
obtained for Ab2535 treated cells (0.2879/0.002), but
similar to the ones of untreated cells (0.2999/0.002) or
treated with the reverse sequence peptide (0.3029/0.002).
As indicated in Table 4, the basal intracellular Ca2
concentration ([Ca2]i), determined by using the cal-
cium-sensitive fluorescent dye Indo-1, is significantly
higher (PB/0.05) in Ab2535-treated cells (155.09/19
nM) than in untreated control cells (109.99/8.3 nM).
4. Discussion
The goal of this study was to test the hypothesis that
Ab2535 enhances AChE activity and that oxidative
stress plays a major role on this process. For this
purpose chick embryo retina cells in culture, which
Fig. 3. (A) Activity of AChE as a function of substrate concentration in control cells (j) and in cells incubated with Ab25  35, in a concentration of
25 mM, for 24 h ('). The rate of AcThCh hydrolysis is plotted as a function of acetylthiocholine concentration (0.03/1.00 mM). The values were
expressed as micromole AcThCh hydrolysed/min/mg protein. (B) Lineweaver/Burk plots (1/V vs 1/S ) for AChE activity of control cells (j) and for
cells incubated with 25 mM Ab25  35 ('). The values are mean9/SEM of 6 independent experiments.
Table 2
Effect of Ab25  35 on kinetic parameters of AChE in retinal cells
Experimental condi-
tion
Km value
(mM)
Vmax value (mmol/min mg
prot.)
Control 0.096 0.18490.02
Ab25  35 treatment 0.068 0.23490.02
The activity of AChE was determined, as described in caption of
Fig. 2, for a range of concentrations 0.03/1.0 mM of the substrate
acetylthiocholine. The values of Km and Vmax were determined using
the Lineweaver/Burk plots (1/V vs 1/S ) (Fig. 3B). Values represent
means9SEM of six different experiments.
 PB0.05 values significantly different from control cells.
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have been proved to be a good neuronal model system
(Agostinho et al., 1996; Santos et al., 1998) and are
highly enriched in cholinergic amacrine-like neurons
(Carvalho et al., 1998; Santos et al., 1998), were used.
The sequence corresponding to amino acids 25/35 of
Ab (Ab2535) forms fibrils and is neurotoxic by a
mechanism similar to that of the full-length peptides
Ab140 or Ab142 (Yankner et al., 1990; Pike et al.,
1993). The concentration of Ab used in this work (25
mM) corresponds approximately to the levels found in
post-mortem brains of AD patients. The concentration
of Ab found has been calculated to be in the order of
100 mg/g of tissue (Hyman et al., 1993), which corre-
sponds to approximately 20 mM, assuming a tissue
density of 1 g/ml (Huang et al., 1999).
Fig. 4. DCF fluorescence of retinal cells untreated (j), treated with Ab25  35 for 24 h ("), incubated with vitamin E (20 mM) for 44 h (') or pre-
treated with vitamin E (20 h prior to the addition of the peptide) and incubated with Ab25  35 for 24 h (m). After treatment, the cells, cultured in glass
coverslips, were incubated with 5 mM of the fluorescent probe DCFH2-DA, for 30 min at 37 8C. After washing, fluorescence was measured using a
computer-assisted spectrofluorophotometer with a thermostated cuvette holder, at 502 nm excitation and 550 nm emission, during 30 min. DCF
fluorescence indicates the formation of intracellular peroxides, as described under Section 2. The values were expressed as arbitrary units and are the
mean of 6 independent experiments. PB/0.05 significantly different compared to control condition, in the absence of Ab25  35 peptide; PB/0.05
values significantly different from retinal cells incubated with Ab25  35.
Fig. 5. Effect of vitamin E and of Ab25  35 on the extent of lipid
peroxidation on retinal cells. Cells were treated with vitamin E alone
(20 mM, 44 h; Vit E), with the peptides, Ab25  35 or Ab35  25 peptide,
(25 mM, 24 h) or with Ab25  35 peptide in cells pre-treated (25 mM, 20 h
prior to the addition of the peptide) with vitamin E (Ab/Vit E). The
extent of cell oxidation was determined by the TBA method, as
described in Section 2, and expressed as nanomole TBARS/mg protein.
Data are the mean9/SEM of 4/11 different experiments, run in
duplicate. PB/0.05 significantly different when compared to control
cells; PB/0.05 values significantly different from retinal cells
incubated with Ab25  35.
Table 3
Effect of Ab25  35 on carbonyl content of retinal cells
Control (n ) Ab25  35 (n )
Carbonyl content (nmol) 5.2990.2 (4) 5.1290.6 (4)
Carbonyl content was determined after exposure of retinal cells to 25
mM Ab25  35, for 24 h. Protein oxidation was determined in cell
suspensions as described in Section 2. Data are expressed as mean-
s9SEM for the number of experiments indicated, run in duplicated.
Fig. 6. Effect of vitamin E and of Ab25  35 peptide on membrane
order. Cells were treated with vitamin E alone (20 mM, 44 h; Vit E),
with the peptides, Ab25  35 or Ab35-25 peptide, (25 mM, 24 h) or with
Ab25  35 peptide in cells pre-treated (25 mM, 20 h prior to the addition
of the peptide) with vitamin E (Ab/Vit E). Cells were incubated with
1.5 mM TMA-DPH in sodium saline solution (pH 7.4) for 20 min, at
37 8C. Fluorescence anisotropy (r ) was determined using a computer-
assisted spectrofluorophotometer, with a thermostated cuvette holder
and a controlled polarizer system, with excitation at 360 nm and
emission at 430 nm. The values of anisotropy (r ) are the means9/SEM
of the number of indicated experiments. PB/0.01 values significantly
different from control cells; PB/0.01 values significantly different
from retinal cells incubated with Ab25  35.
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In our experimental conditions, Ab2535 treatment
did not affect retinal cell membrane integrity, given by
LDH release (Table 1). However, the cellular metabolic
capacity, evaluated by MTT assay, showed to be
compromised by the exposure to the amyloidogenic
peptide (Table 1). These data suggest that Ab2535
treatment induced a moderate cell injury, since mem-
brane cell integrity was not significantly altered. Several
mechanisms have been proposed for Ab peptides-
mediated neurotoxicity. Some authors reported that in
a conformation-dependent manner Ab and the C-
terminal region of APP compromise neurons viability
via the rapid disruption of intracellular Ca2 home-
ostasis (Mattson et al., 1992, 1995; Fraser et al., 1996)
and that Ab potentiates glutamate toxicity by the
generation of Ca2 transmembrane fluxes (Gray and
Pattel, 1995).
Another mechanism suggested to be involved in Ab
peptides-induced neurotoxicity is the generation of ROS
(Behl et al., 1994; Butterfield et al., 1994; Pereira et al.,
1999) which seems to be responsible for cell membrane
lipid peroxidation (Mattson et al., 1992; Behl et al.,
1994; Mark et al., 1997b). Peroxidation of membrane
unsaturated fatty acids generates several aldehydes, such
as malonildialdehyde and 4-hydroxy-2,3-nonenal (4-
HNE) (Esterbauer et al., 1991). 4-HNE was also shown
to be generated by Ab (Mark et al., 1997a), impairing
the function of membrane proteins, such as ion-motive
ATPases and voltage Ca2 channels, that ultimately
lead to the disruption of ion homeostasis (Mark et al.,
1997b). The three isoforms (neuronal, endothelial and
inducible) of the nitric oxide-synthesizing enzyme, NOS,
are aberrantly expressed in AD giving rise to elevated
levels of nitric oxide (NO). In addition to its vasoactive
and immunological properties, NO has significant
neurophysiological functions. However, NO can also
be neurotoxic primarily due to its free radical properties
(Law et al., 2001b). NO seems to be involved in AD by
different mechanisms including oxidative stress and
activation of intracellular signalling mechanisms (Luth
et al., 2001). Ab showed to increase NO release,
decreasing cellular viability, in primary cortical cultures
(Law et al., 2001a) and to increase NO production in rat
hippocampus (Tran et al., 2001). We have observed that
Ab2535 increases significantly (PB/0.05) ROS produc-
tion (Fig. 4) and lipid peroxidation levels (Fig. 5), and
that pre-treatment of the cells with the antioxidant
vitamin E (20 mM) prevents these oxidative events. Rego
et al. (1998) have also shown that vitamin E, in the
concentration used in this study and during the same
incubation period, reduces the extent of lipid peroxida-
tion when chick retinal cells are exposed to peroxidizing
conditions. We have also observed that Ab2535 in-
creases basal [Ca2]i (Table 4). There is growing
evidence for a possible link between an increase in
[Ca2]i and an enhanced generation of ROS (Dutrait et
al., 1995; Mattson et al., 1995). Recent reports show that
an increase in cell Ca2 influx, mainly through voltage-
sensitive Ca2 channels, precedes ROS formation and
the subsequent lipid peroxidation in cultured cells
exposed to Ab (Ekinci et al., 1999, 2000), suggesting
that the concerted appearance of these neurotoxic events
may accelerate Ab-induced neuronal damage (Mattson,
1998).
A direct consequence of lipid peroxidation is the
alteration of cell membrane order (Rego and Oliveira,
1995). We observed an increase in membrane fluidity in
retinal cells exposed to the amyloidogenic peptide,
Ab2535, by using the fluorescent probe TMA-DPH
(Fig. 6). Changes in TMA-DPH fluorescent anisotropy
mainly reflect the alteration of membrane order in the
glycerol and upper regions of the lipid bilayer (Pre-
ndergast et al., 1981). At the initial periods of peroxida-
tion the decrease in membrane order indicates a
disordering effect at the level of phospholipid head
groups and at the upper part of fatty acyl chains,
whereas the progression of fatty acyl chain oxidation
may contribute to the enhancement of cell membrane
rigidity (Dobretsov et al., 1977; Rego and Oliveira,
1995). The Ab2535-induced increase of cell membrane
fluidity (lower values of TMA-DPH fluorescence aniso-
tropy) was prevented by the antioxidant vitamin E (Fig.
6), further supporting the hypothesis that Ab2535
induces oxidative stress and membrane lipid peroxida-
tion.
Several studies in AD brains have demonstrated that
changes occur in the expression and distribution of
AChE (Massoulie´ et al., 1993). Furthermore, most of
the cortical AChE activity present in AD brains has
been found associated with senile plaques, where it co-
localizes with Ab deposits (Kasa et al., 1997). In vitro,
AChE promotes the aggregation of Ab in amyloid fibrils
(Inestrosa et al., 1996) and forms a complex with Ab,
which has a higher toxic effect than Ab (Alvarez et al.,
1997, 1998). These authors also reported that the kinetic
properties of Ab-AChE complexes differ from those of
Table 4
Effect of Ab25  35 on intracellular calcium levels of retinal cells
Control (n ) Ab25  35 (n )
[Ca2]i basal (nM) 109.998.3 (10) 155.0919 (6)
After exposure or not (control) to Ab25  35 (25 mM) for 24 h, retinal
cells were loaded with Indo-AM for 45 min at 37 8C. Cells were
further incubated in Krebs buffer for 15 min, in order to obtain the
hydrolysis of the probe to Indo-1. Intracellular calcium levels were
determined by spectrofluorophotometry with excitation wavelength of
335 nm and emission at 410 nm. Values represent means9SEM of the
number of experiments indicated.
 PB0.05 significantly different compared to control condition, in
the absence of Ab25  35 peptide.
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the free enzyme, with Km and Vmax values higher for
Ab-AChE, the complexed enzyme being more resistant
to low pH conditions, to inhibition by anticholinestease
agents or by the excess of substrate. We report here that
Ab2535 peptide leads to a significant (PB/0.001)
increment in AChE activity, with an increase in Vmax
and a decrease in Km values (Table 2). These results
suggest that a change in enzyme conformation occurs,
leading to an increase in substrate-enzyme affinity
(lower Km values) and enzyme activity. The effect
observed for Ab2535 is specific of this neurotoxic
sequence, because the reverse sequence peptide,
Ab3525, did not affect cell viability or AChE activity
(Table 1 and Fig. 2). In accordance with our results, Ab
was shown to induce the expression of AChE in the
brains of CT-100-expressing transgenic mice (Sberna et
al., 1998). Furthermore, in another study using human
CSF samples, Ab levels were found to have a significant
and positive correlation with cholinesterase activity
(Carroll et al., 1999). Sberna et al. (1997) reported that
Ab increments AChE activity in P19 cells by increasing
calcium entry through L-type voltage-dependent calcium
channels, suggesting that the increase of AChE expres-
sion around amyloid plaques is a consequence of a
disturbance of calcium homeostasis. In our experimental
conditions, we also observed an increase in basal Ca2
intracellular levels induced by Ab, which can be related
to the increase in AChE activity. We also showed that
vitamin E, a well-known lipid peroxidation chain break-
ing antioxidant, and NOS inhibitors (7-Nitroindazole
and L-NAME) prevent Ab2535-induced AChE activity
enhancement. This evidence suggests a role for ROS on
the increase of AChE activity. Moreover, after 18 h
incubation with Ab2535 ROS levels increase, although
the activity of AChE (1129/7.7%) was not significantly
(P/0.05) affected, suggesting that ROS generation
precedes the increase of AChE. An indirect role for
Ca2 influx in the impairment of enzyme activity,
leading to an increase in ROS production and conse-
quently to membrane lipid peroxidation, cannot be
ruled out. It is likely that the impairment of AChE is
due to lipid peroxidation and changes in membrane
order rather than to protein oxidation, because the
content in carbonyl group was not affected by Ab
treatment (Table 3).
Taken together our data suggest that calcium influx
followed by oxidative stress is involved in the increased
activity of AChE induced by Ab2535 peptide, decreas-
ing cell membrane order and ultimately leading to the
exposure of more active sites of the enzyme. The
observation that Ab peptide increases AChE activity
and ROS production indicates that it can be possible to
ameliorate cholinergic function, by inhibiting Ab-in-
duced increase in AChE activity.
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